Stockscreener 앱 받기
227.90
8.61%
18.07
시장 영업 전:
227.90
Quest Diagnostics Inc 주식(DGX)의 최신 뉴스
Quest Diagnostics stock trades steady as investors weigh recent earnings and diagnostics demand - Ad-hoc-news.de
Trending Industry Today: Quest Diagnostics Leads Gains In CRO Stocks - Moomoo
Quest Diagnostics Incorporated (DGX) Stock Forecasts - Yahoo Finance
Quest Diagnostics Inc (DGX) Shares Surge 8.6% -- What GF Score o - GuruFocus
Quest Continues to Build on Its Hospital Lab Collaborations - Morningstar
Quest Diagnostics Incorporated Stock 12‑Month Price Target Raised to $229.6, Implies 9% Upside - TradingView
Quest Diagnostics Inc (DGX) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
Quest Diagnostics Inc (DGX) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amid Operational Challenges - GuruFocus
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Quest Diagnostics 2026: Revenue $3.04B, EPS $2.84— 10-Q Summary - TradingView
Quest Diagnostics (NYSE: DGX) lifts Q2 EPS to $2.84 on 10% revenue growth - Stock Titan
Quest Diagnostics Q2 Earnings Call Highlights - Yahoo Finance
Quest Diagnostics Stock Gains As Oncology Moves Impress Wall Street - StocksToTrade
Quest Diagnostics Stock Hits 52-Week HighHere's WhyQuest Diagnostics (NYSE:DGX) - Benzinga
Quest Diagnostics raises annual forecast on testing demand - Reuters
Quest Diagnostics Q2 2026 Results: Revenue Surges 10%, EPS Up 19%, Full-Year Guidance Raised - Minichart
Quest Diagnostics Announces Q2 2026 Financial Results and Operational Highlights - Kalkine Media
Lockheed Martin, Quest Diagnostics, Thermo Fisher Scientific And Other Big Stocks Moving Higher On Thursday - Benzinga
Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010. - marketscreener.com
Quest Diagnostics stock hits all-time high at 227.31 USD By Investing.com - Investing.com Canada
Transcript: Quest Diagnostics Q2 2026 Earnings Conference Call - Benzinga
DGX Stock Up on Q2 Earnings & Revenue Beat, '26 View Raised - TradingView
Quest Diagnostics Incorporated (DGX) Q2 FY2026 earnings call transcript - Yahoo Finance
Quest’s (NYSE:DGX) Q2 CY2026: Beats On Revenue, Stock Soars - Yahoo Finance
Quest Diagnostics (DGX) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Finance
Quest Diagnostics raises full-year guidance after Q2 revenue rises 10.2% - scanx.trade
Is Quest Diagnostics Inc (DGX) Overvalued After Q2 Earnings Beat - GuruFocus
Quest Diagnostics (NYSE:DGX) Surges After Crushing Q2 Estimates and Raising Guidance - ChartMill
Quest Diagnostics Q2 Adjusted Earnings, Revenue Rise - marketscreener.com
Quest Diagnostics stock rises 5% on strong Q2 beat, raised guidance - Investing.com Canada
(DGX) Quest Diagnostics Expects Full Year 2026 Revenue Range $11.95B$12.05B, vs. FactSet Est of $11.85B - marketscreener.com
Earnings Flash (DGX) Quest Diagnostics Incorporated Reports Q2 Revenue $3.04B, vs. FactSet Est of $2.97B - marketscreener.com
Earnings Flash (DGX) Quest Diagnostics Incorporated Posts Q2 Adjusted EPS $3.12 per Share, vs. FactSet Est of $2.82 - marketscreener.com
Quest Diagnostics (DGX) Earnings Surpass Estimates with Raised FY Adj EPS Forecast - Smartkarma
Quest Diagnostics: Q2 Earnings Snapshot - Yahoo Finance
Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 - PR Newswire
Quest Diagnostics earnings on deck as testing growth accelerates By Investing.com - Investing.com Canada
Quest Diagnostics stock trades steadily as recent earnings and data volumes shape outlook - Ad-hoc-news.de
Global Cancer Biomarkers Market to Reach $37.8 Billion by 2035 as Precision Oncology Adoption Accelerates - GlobeNewswire Inc.
Quest Diagnostics stock trades steadily as investors weigh recent revenue growth and dividend income - Ad-hoc-news.de
Quest Diagnostics Inc. stock underperforms Monday when compared to competitors - MarketWatch
Quest Diagnostics | SCHEDULE 13G/A: Others - Moomoo
Quest Diagnostics stock trades steadily as investors weigh steady revenue and margin trends - Ad-hoc-news.de
Is Quest Diagnostics Inc (DGX) Overvalued After 3.8% Rally? GF V - GuruFocus
A 9-Day Losing Streak Has Quest Diagnostics Stock Down 6.2% - Trefis
Quest Diagnostics stock holds steady as diagnostics demand underpins long term growth - Ad-hoc-news.de
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Leerink Partners Adjusts Quest Diagnostics Price Target to $244 From $240, Maintains Outperform Rating - marketscreener.com
Quest Diagnostics Currently Down Nine Consecutive Days, on Pace for Longest Losing Streak Since September 2001 -- Data Talk - Moomoo
A4ET8Q Bond Profile — Key Metrics - TradingView
Quest Diagnostics to Report Q2 Earnings: Key Customer Channels in Focus - Zacks Investment Research
A28XES Bond Risk Profile - TradingView
US74834LBB53 Bond Coupon Profile — Rate & Payments - TradingView
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Quest Diagnostics (DGX) and Gilead Sciences (GILD) - The Globe and Mail
BofA Securities Maintains Quest Diagnostics(DGX.US) With Buy Rating, Raises Target Price to $245 - Moomoo
Baird Maintains Quest Diagnostics(DGX.US) With Hold Rating, Raises Target Price to $236 - Moomoo
Quest Diagnostics stock holds steady as diagnostics demand supports long-term growth - ad-hoc-news.de
Quest Diagnostics (NYSE:DGX) Offers a Secure and Sustainable Dividend with Strong Profitability - ChartMill
Quest Diagnostics (DGX) Proxy filing Summary - Quartr
Quest Diagnostics (DGX) Q4 2025 earnings summary - Quartr
Marijuana drives half of 2025 worker hair drug positives as fentanyl rates fall - Stock Titan
Quest Diagnostics stock stays supported by steady diagnostics demand - Ad-hoc-news.de
3.57%
자본화:
|
볼륨(24시간):